RemeGen Co., Ltd. 榮昌生物製藥(煙台)股份有限公司

Pay for financial year ended 2024-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Supervisors

1 Li, Yupeng (1983) 李宇鵬 Supervisor
2 Li, Zhuanglin 李壯林 Supervisor 1,746 520 42 2,308
3 Ren, Guangke 任廣科 Sup Ch 800 144 42 986
Total 0 2,546 664 84 0 3,294

Directors

4 Chen, Yunjin 陳雲金 INED 300 300
5 Fang, Jianmin (1962) 房健民 CEO, Co-Fdr 712 4,876 1,759 42 7,389
6 Hao, Xianjing 郝先經 INED 300 300
7 He, Ruyi (1961) 何如意 ED 5,202 267 10,177 15,646
8 Lin, Jian (1955) 林健 ED 480 329 167 976
9 Ma, Lan (1957) 馬蘭 INED 262 262
10 Su, Xiaodi 蘇曉迪 NED
11 Wang, Liqiang (1970) 王荔強 NED
12 Wang, Weidong (1959) 王威東 Ch 2,130 420 7,813 10,363
Total 1,574 12,688 2,775 42 18,157 35,236
Grand total 1,574 15,234 3,439 126 18,157 38,530

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,574 12,688 2,775 42 18,157 35,236 Report
2023-12-31 2,317 14,409 3,709 41 35,376 55,852 Report
2022-12-31 2,293 14,414 3,878 77 36,763 57,425 Report
2021-12-31 900 8,914 5,313 72 6,271 21,470 Report
2020-12-31 576 10,114 2,983 6 4,648 18,327 Report
Total 7,660 60,539 18,658 238 101,215 188,310

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top